Optimizing Treatment for Hyperpigmentation
Pearl Grimes, MD, Medical Director of The Vitiligo & Pigmentation Institute of Southern California and a Clinical Professor of Dermatology at the University of California, Los Angeles, discusses advances in understanding the pathogenesis of melasma and post-inflammatory hyperpigmentation and shares how she integrates new non-hydroxychloroquine products into her treatment regimens for hyperpigmentation.